Device Week – October 7, 2016
Executive Summary
On this week's podcast, Medtech Insight journalists discuss FDA approval trends, Trinity Biotech's 510(k) withdrawal for its point-of-care cardiac troponin assay, an HHS Inspector General look at the costs of recalled devices, and more.